Ainos (AIMD) News Today $0.68 -0.03 (-3.93%) Closing price 04:00 PM EasternExtended Trading$0.66 -0.02 (-3.11%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Ainos, Inc.: Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral InnovationJanuary 27 at 12:44 PM | finanznachrichten.deAinos (OTCMKTS:AIMD) Shares Up 19% - Should You Buy?January 23, 2025 | americanbankingnews.comAinos, Inc.: Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled RobotsJanuary 14, 2025 | finanznachrichten.deAinos, Inc.: CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONADecember 18, 2024 | finanznachrichten.deAinos Inc. secures stockholder nod for special stock awardsOctober 3, 2024 | investing.comAinos, Inc.: Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral WartsSeptember 20, 2024 | finanznachrichten.deWhy Is Ainos (AIMD) Stock Up 38% Today?August 12, 2024 | msn.comAinos, Inc.: Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential MarketMay 15, 2024 | finanznachrichten.deSOS, MFG and LYT among pre-market losersMarch 11, 2024 | msn.comAinos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)March 10, 2024 | finance.yahoo.comAinos, Inc.: Ainos Reports Full Year 2023 Financial ResultsMarch 8, 2024 | finanznachrichten.deNasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In FebruaryMarch 8, 2024 | markets.businessinsider.comAinos IncMarch 4, 2024 | edition.cnn.comAinos Stock (NASDAQ:AIMD), Short Interest ReportFebruary 23, 2024 | benzinga.comSmall-Cap Growth Virtual Investor Conference Presentations Now Available for Online ViewingFebruary 8, 2024 | finance.yahoo.comAinos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7thFebruary 1, 2024 | finance.yahoo.comUS Stocks Higher; Payrolls Increase By 216,000 In DecemberJanuary 5, 2024 | msn.comWhy Is Ainos (AIMD) Stock Up 157% Today?January 5, 2024 | investorplace.comAinos, Inc.: Ainos Regains Compliance with Nasdaq Minimum Bid Price RequirementJanuary 2, 2024 | finanznachrichten.deAinos Regains Compliance with Nasdaq Minimum Bid Price RequirementJanuary 2, 2024 | finance.yahoo.comAinos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of SmellDecember 26, 2023 | finance.yahoo.comAinos implements a reverse stock splitDecember 12, 2023 | msn.comAinos, Inc. Announces Stock ConsolidationDecember 12, 2023 | finance.yahoo.comAinos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss PharmaceuticalNovember 28, 2023 | finance.yahoo.comAinos GAAP EPS of -$0.15November 10, 2023 | msn.comAinos Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | finance.yahoo.comAinos Inc AIMDNovember 8, 2023 | morningstar.comAinos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONANovember 6, 2023 | finance.yahoo.comAinos Announces Placement of Initial $3 Million Tranche of $10 Million Private PlacementSeptember 25, 2023 | finance.yahoo.comWith Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV PatientsSeptember 19, 2023 | finance.yahoo.comAinos, Inc.: Ainos' VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsSeptember 18, 2023 | finanznachrichten.deAinos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsSeptember 18, 2023 | finance.yahoo.comAinos, Inc.: Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in TaiwanSeptember 5, 2023 | finanznachrichten.deAinos Commences Shipping its VELDONA Pet Cytoprotein Supplements in TaiwanSeptember 5, 2023 | finance.yahoo.comAinos Celebrates First Listing Anniversary on NasdaqAugust 29, 2023 | finance.yahoo.comAinos, Inc - The AI Nose "Knows" What's Inside Your Body and BeyondAugust 15, 2023 | finance.yahoo.comAinos, Inc.: Ainos Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | finanznachrichten.deAinos Reports Second Quarter 2023 Financial ResultsAugust 11, 2023 | finance.yahoo.comWhy Is Theseus Pharmaceuticals (THRX) Stock Down 68% Today?July 14, 2023 | msn.comWhy Is Ainos (AIMD) Stock Up 82% Today?July 14, 2023 | msn.comAinos, Inc.: Ainos Issues Mid-Year Business Update Letter to ShareholdersJune 27, 2023 | finanznachrichten.deAinos Issues Mid-Year Business Update Letter to ShareholdersJune 27, 2023 | finance.yahoo.comAinos, Inc.: Ainos Provides Insights Into Its AI Nose TechnologyJune 20, 2023 | finanznachrichten.deAinos Provides Insights Into Its AI Nose TechnologyJune 20, 2023 | finance.yahoo.comAinos, Inc.: Ainos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue TargetJune 14, 2023 | finanznachrichten.deAinos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue TargetJune 14, 2023 | finance.yahoo.comAinos, Inc.: Ainos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales TargetJune 7, 2023 | finanznachrichten.deAinos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales TargetJune 7, 2023 | finance.yahoo.comAinos, Inc.: Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in SalesMay 30, 2023 | finanznachrichten.deAinos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in SalesMay 30, 2023 | finance.yahoo.com Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Email Address AIMD Media Mentions By Week AIMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AIMD News Sentiment▼0.850.74▲Average Medical News Sentiment AIMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AIMD Articles This Week▼10▲AIMD Articles Average Week Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTVT News ICCC News MRMD News VYNE News ITRM News NRXP News ATNM News BRNS News TPST News RAPT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AIMD) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
